Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Find a clinical trial that's recruiting now
Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.
- 24,857
- trials recruiting now
- 14%
- of all US trials open to enrollment
- 52
- states with recruiting sites
A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.
Popular conditions
100 trials found
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
St. Jude Children's Research Hospital
NCT01354002
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Baylor Research Institute
NCT01904851
Innovations in Genicular Outcomes Registry
Pacira Pharmaceuticals
NCT05495334
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
M.D. Anderson Cancer Center
NCT00539162
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Colorado Prevention Center
NCT06008197
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy
Massachusetts General Hospital
NCT01696721
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
George Washington University
NCT06525259
International Care Bundle Evaluation in Cerebral Hemorrhage Research
Region Skane
NCT06429332
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
Minneapolis Heart Institute Foundation
NCT04077762
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
Exactech
NCT05849961
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Elephas
NCT07327489
Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Kailera
NCT07284875
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Concept Medical
NCT06271590
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Bristol-Myers Squibb
NCT07379827
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
AstraZeneca
NCT06921785
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Kailera
NCT07284979
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
University of Calgary
NCT05219110
Pain and Opioid Management in Older Adults
University of Oklahoma
NCT05037682
iAmHealthy Clinical Practice Guideline (CPG)
University of Kansas Medical Center
NCT06888011
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry
SCAD Alliance
NCT04496687
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
Cleerly
NCT06713239
The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals
Mayo Clinic
NCT06087224
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Sanofi
NCT05769777
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Hoffmann-La Roche
NCT07174310
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma.
Sanofi
NCT06609239
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Regeneron Pharmaceuticals
NCT03564340
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
St. Jude Children's Research Hospital
NCT06289673
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
ModernaTX
NCT07089706
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Indiana University
NCT05124808
Physica System Total Knee Replacement Registry Study
Limacorporate S.p.a
NCT03048201
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
University of Oklahoma
NCT06488781
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Merck Sharp & Dohme
NCT06824467
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Genmab
NCT05579366
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis
Janssen Research & Development
NCT06807424
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
National Cancer Institute (NCI)
NCT06498661
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Amgen
NCT07213674
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Corxel Pharmaceuticals
NCT06990867
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Hospital for Special Surgery, New York
NCT00198068
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Reviva Pharmaceuticals
NCT05184335
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Axsome Therapeutics
NCT07398417
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Glaukos Corporation
NCT07075718
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
Weill Medical College of Cornell University
NCT03256240
Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness
University of Oklahoma
NCT06821295
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Biotest
NCT05722938
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
NCT07196501
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Immunocore
NCT05549297
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Revolution Medicines
NCT06128551
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Merus B.V.
NCT03526835
Stress Hydrocortisone In Pediatric Septic Shock
Jerry Zimmerman
NCT03401398
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Integra LifeSciences Corporation
NCT04494295
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
National Cancer Institute (NCI)
NCT07281430
VIA Disc NP Registry 3.0
VIVEX Biologics
NCT06345690
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Biohaven Therapeutics
NCT06384807
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
National Cancer Institute (NCI)
NCT06311214
A Study of Buntanetap in Participants With PD
Annovis Bio
NCT07284784
AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
Amgen
NCT06333951
AngelMed Guardian® System PMA Post Approval Study
Angel Medical Systems
NCT05412927
PDN Post Market, Multicenter, Prospective, Global Clinical Study
Nevro
NCT05301816
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
J-Pharma Co.
NCT07265674
Tribally Engaged Approaches to Lung Screening (TEALS)
University of Oklahoma
NCT04948060
Acellular Dermal Matrix Investigation in Breast Reconstruction
RTI Surgical
NCT06456554
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Incyte Corporation
NCT07214779
Connect2Care: Prostate Cancer Education and Screenings for African American Men
University of Oklahoma
NCT07055165
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Insel Gruppe AG, University Hospital Bern
NCT01257269
The OBSERVE Protocol
Yale University
NCT06725277
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Blueprint Medicines Corporation
NCT07143669
AltaValve Pivotal Trial
4C Medical Technologies
NCT06465745
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
AstraZeneca
NCT07088926
Study of AVZO-021 in Patients With Advanced Solid Tumors
Avenzo Therapeutics
NCT05867251
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Exelixis
NCT05932862
A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination
Selecxine
NCT05525247
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
University of Oklahoma
NCT07014618
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Boston Scientific Corporation
NCT06735534
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
Yale University
NCT06713616
BostonGene and Exigent Genomic INsight Study
BostonGene
NCT06272864
Study of XB010 in Subjects With Solid Tumors
Exelixis
NCT06545331
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Clarity Pharmaceuticals
NCT06056830
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
Mayo Clinic
NCT07100990
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Atom Therapeutics Co.
NCT07145229
Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow
University of Michigan
NCT04254185
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
University of Alabama at Birmingham
NCT05026749
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Marengo Therapeutics
NCT05592626
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Vicore Pharma AB
NCT06588686
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
Fate Therapeutics
NCT06241456
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
University of Washington
NCT06893939
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Abiomed
NCT06964685
A Study of NX-1607 in Adults With Advanced Malignancies
Nurix Therapeutics
NCT05107674
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
OHB Neonatology
NCT03253263
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
Jazz Pharmaceuticals
NCT05557045
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
NYU Langone Health
NCT05799378
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
Takeda
NCT05156983
Different Doses of Naronapride Vs. Placebo in Gastroparesis
Dr. Falk Pharma
NCT05621811
A Study of XMT-1660 in Participants With Solid Tumors
Mersana Therapeutics
NCT05377996
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
NICHD Neonatal Research Network
NCT06679855
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Xencor
NCT05433142
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Kura Oncology
NCT06026410
CRF2 Agonist for the Treatment of Worsening Heart Failure
Corteria Pharmaceuticals
NCT06815471
Meloxicam in Mohs Micrographic Surgery
University of Oklahoma
NCT07200544
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Merck Sharp & Dohme
NCT06655883
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
University of Oklahoma
NCT07162935
Read our methodology - how recruiting status is sourced and refreshed from the public registry.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.